The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on ...

Better-than-expected financial results in recent quarters have signaled an improved outlook, helping to sustain the rally.

Shares of Bristol Myers Squibb Co. BMY shed 2.36% to $59.55 Tuesday, on what proved to be an all-around mixed trading session ...

Shares of Bristol Myers Squibb Co. BMY advanced 1.90% to $60.02 Friday, on what proved to be an all-around dismal trading ...

Equities research analysts at Zacks Research dropped their Q1 2027 earnings per share (EPS) estimates for shares of ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report), with a ...

Bullish option flow detected in Bristol Myers ( BMY) Squibb with 37,216 calls trading, 3x expected, and implied vol increasing almost 3 points to 39.30%. Jan-26 25 calls and May-25 43 calls are the ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) was the target of a significant growth in short interest during the month ...

During a special ceremony, the mayor presented a proclamation to Cari Gallman, Executive Vice President of Corporate Affairs ...